Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T Cell-B cell antibody synthesis

Journal of Clinical Immunology

Volumn 16, Issue 4, 1996, Pages 198-207

  Al Janadi, Mansour ^a   Al Dalaan, Abdullah ^b   Al Balla, Suliman ^a   Al Humaidi, Mohammed ^a   Raziuddin, Syed ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Autoimmunity; CD4+CD45RO T cells; Interleukin 10; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD45 ANTIGEN; INTERLEUKIN 10;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ETIOLOGY; FEMALE; HUMAN; MALE; MEMORY CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; ANTIGENS, CD45; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES;

EID: 0029924744     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01541225     Document Type: Article

References (40)

1. Florentino DF, Bond MW, Mosmann TR: Two types of mouse helper T cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2084, 1989
2. O'Gara A, Stapleton G, Dhar V, Pearce M, Schumacher J, Rugo H, Barbis D, Stall A, Cupp J, Moore K, Vieira P, Mosmann T, Whitmore A, Arnold L, Haugton G, Howard M: Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2:821-832, 1990
3. de Waal MR, Abrams J, Bennett B, Figdor C, de Vries JE: IL-10 inhibits cytokine synthesis by human monocytes. An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
4. Fiorentino DF, Zlotnik A, Mossmann TR, Howard M, O'Gara A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991
5. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick D: Interleukin-10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507-510, 1991
6. Zlotnik A, Moore KW: Interleukin-10. Cytokines 3:366-371, 1991
7. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ. IL-10 mediates susceptibility to trypanosoma cruzi infection. J Immunol 153:3135-3140, 1994
8. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell derived cytokine. Annu Rev Immunol 10:385-399, 1992
9. Howard M, O'Garra A, Ishida H, de Waal MR, de Vries J: Biological properties of interleukin-10. J Clin Immunol 12:239-247, 1992
10. Moore KW, O'Garra A, de Waal MR, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
11. Hahn BH: An overview of the etiology and pathogenesis of systemic lupus erythematosus. In Systemic Lupus Erythematosus, 4th ed, Wallace, Hahn (eds). Philadelphia, Lea & Fibger, 1992, pp 65-70
12. Paget SA, Gibofsky A: Immunopathogenesis of rheumatoid arthritis. Am J Med 67:961-970, 1979
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systmic lupus erythematosus. Arth Rheum 25:1271-1277, 1982
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31:315-324, 1988
15. Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S: Cytokine production by helper T cell populations from the synovial fluid and blood in patients with rheumatoid arthritis. J Rheumatol 20:1647-1653, 1993
16. Al-Janadi M, Raziuddin S: B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 20:1885-1891, 1993
17. Klinman DM: B cells. In Steinberg AD, moderator. Systemic lupus erythematosus. Ann Intern Med 115:550-555, 1991
18. Ueda Y, Sakane T, Tsunematsu T: Hyperactivity of activated B cells to B cell growth factor in patints with systemic lupus erythematosus. J Immunol 143:3988-3993, 1989
19. Raziuddin S, Al-Janadi M, Al-Wabel AA: Soluble interleukin-2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestation of the disease in patients with systemic lupus erythematosus. J Rheumatol 18:831-836, 1991
20. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinberg JR: Elevated levels of endogeneous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117-123, 1991
21. Hochberg MC: Systemic lupus erythematosus. Rheum Dis Clin North Am 16:613-639, 1990
22. Raziuddin S, Nur MA, Al-Wabel AA: Selective loss of the CD4+ inducers of T cell subsets (2H4) in active systemic lupus erythematosus. J Rheumatol 16:1315-1319, 1989
23. Morimoto C, Romain PL, Fox DA, Schlossman SF: Abnormalities in CD4+ T lymphocyte subsets in inflammatory rheumatic diseases. Am J Med 84:817-825, 1988
24. Emery P, Gentry KC, Makay IR, Muirden KD, Rowley M: Deficiency of the suppressor-inducer subsets of T lymphocytes in rheumatoid arthritis. Arth Rheum 30:849-856, 1987
25. Morimoto C, Steinberg AD, Letvin NL, Fox DA, Romain PL, Schlossman SF: A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated by anti-2H4 antibody. J Clin Invest 79:762-768, 1987
26. Horwitz DA, Wang HA, Gray JD: Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: Increased interleukin-2 but not interleukin-4 mRNA. Lupus 3:423-428, 1994
27. Zagon G, Tumang JR, Li Y, Friedman ST, Crow MK: Increased frequency of Vb17-positive T cells in patients with rheumatoid arthritis. Arth Rheum 37:1431-1440, 1994
28. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Smolen J, Graninger WB. High levels of bcl-2 protein in circulating lymphocytes but not B lymphocytes of patients with systemic lupus erythematosus. Arth Rheum 37:1423-1430, 1994
29. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC: serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 82:2169-2174, 1993
30. Smilie D, Touitou R, Raphel M, Peuchmaur M, Devergnee O, Rea D, Galanaud P: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 22:2937-2942
31. Baiocchi R, Ross ME, Tan JC, Chou CC, Sulivan L, Sklar J, Croce CM, Caligiuri MA: Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood 85:1063-1074, 1995
32. Katsikis PD, Chu CQ, Brenan FM, Mainin RN, Feldmann M. Immunoregulatory role in interleukin-10 in RA. J Exp Med 179:1517-1521, 1994
33. Taga K, Chernay B, Tosato G: IL-10 inhibits apoptic cell death in humans T cells starved of iL-2. Int Immunol 5:1599-1604, 1993
34. Cohen SB, Katsikis PD, Feldmann M, Londei M: IL-10 enhance expression of the IL-2 receptor a chain on T cells. Immunology 83:329-332, 1994
35. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145:4167-4172, 1990
36. Via CS, Handwerger BS: T cell and B cell function in lupus. Curr Opinion Rhumatol 4:630-634, 1992
37. Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T: Antigen-induced apoptic death of Ly 1 (CD5+) B cells responsible for autoimmune disease in transgenic mice. Nature 357:77-80, 1992
38. O'Gara A, Chang R, Hastings R, Go N, Haughton G, howard M: Ly1B (B1) cells are the main source of B cell derived IL-10. Eur J Immunol 22:711-717, 1992
39. Ishida H, Hastings R, Kearney J, Howard M: Continuous anti-IL-1 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175:1213-1220, 1992
40. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin-10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310, 1994